Financial News
Glycomimetics Inc (NQ: GLYC )
0.2900
-0.0062
(-2.09%)
Streaming Delayed Price
Updated: 9:38 AM EDT, Jul 19, 2024
Add to My Watchlist
All News about Glycomimetics Inc
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17392.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220909005218/en/1566730/5/Logo-Glyco.jpg)
GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
September 09, 2022
From GlycoMimetics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220907005136/en/1560445/5/Logo-Glyco_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16306.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7811.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4417.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2458.jpeg)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://mms.businesswire.com/media/20220906005157/en/1560445/5/Logo-Glyco_%28002%29.jpg)
GlycoMimetics Appoints Edwin Rock, M.D., Ph.D. as Chief Medical Officer
September 06, 2022
From GlycoMimetics, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/09/06/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14743.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14619.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220803005327/en/1533182/5/Logo-Glyco.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20220602005808/en/1475021/5/Logo-Glyco.jpg)
![](https://mms.businesswire.com/media/20220428005431/en/1436071/5/Logo-Glyco.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3918.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_581.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_404.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3665.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2430.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1217.jpeg)
![](https://mms.businesswire.com/media/20220225005259/en/1371908/5/Logo-Glyco.jpg)
![](https://mms.businesswire.com/media/20220223006040/en/1369314/5/Logo-Glyco.jpg)
From GlycoMimetics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220223006032/en/1369306/5/Logo-Glyco.jpg)
![](https://mms.businesswire.com/media/20211213005560/en/1303942/5/Logo-Glyco.jpg)
![](https://mms.businesswire.com/media/20211206005485/en/933277/4/NCI.jpg)
![](https://mms.businesswire.com/media/20211123006145/en/930158/5/Logo-Glyco.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.